Search

Christopher R. Stone

Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1609, 1614, 1628, 4173
Total Applications
750
Issued Applications
250
Pending Applications
42
Abandoned Applications
457

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5558805 [patent_doc_number] => 20090270382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Soluble epoxide hydrolase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/426136 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17831 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270382.pdf [firstpage_image] =>[orig_patent_app_number] => 12426136 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/426136
Soluble epoxide hydrolase inhibitors Apr 16, 2009 Abandoned
Array ( [id] => 5404764 [patent_doc_number] => 20090240079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 12/421442 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11417 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20090240079.pdf [firstpage_image] =>[orig_patent_app_number] => 12421442 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421442
Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases Apr 8, 2009 Abandoned
Array ( [id] => 5474433 [patent_doc_number] => 20090247599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE' [patent_app_type] => utility [patent_app_number] => 12/420109 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8222 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247599.pdf [firstpage_image] =>[orig_patent_app_number] => 12420109 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/420109
METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE Apr 7, 2009 Abandoned
Array ( [id] => 10089005 [patent_doc_number] => 09125809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Pectin-containing jelly formulation' [patent_app_type] => utility [patent_app_number] => 13/262800 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5562 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262800 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262800
Pectin-containing jelly formulation Apr 2, 2009 Issued
Array ( [id] => 5474328 [patent_doc_number] => 20090247494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders' [patent_app_type] => utility [patent_app_number] => 12/414414 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 649 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247494.pdf [firstpage_image] =>[orig_patent_app_number] => 12414414 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/414414
Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders Mar 29, 2009 Abandoned
Array ( [id] => 5404587 [patent_doc_number] => 20090239901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'METHOD AND COMPOSITIONS FOR TREATMENT OF CEREBRAL MALARIA' [patent_app_type] => utility [patent_app_number] => 12/407010 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 1881 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239901.pdf [firstpage_image] =>[orig_patent_app_number] => 12407010 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/407010
METHOD AND COMPOSITIONS FOR TREATMENT OF CEREBRAL MALARIA Mar 18, 2009 Abandoned
Array ( [id] => 6136683 [patent_doc_number] => 20110009404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => '4-ARYL-2-ANILINO-PYRIMIDINES' [patent_app_type] => utility [patent_app_number] => 12/921499 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35973 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009404.pdf [firstpage_image] =>[orig_patent_app_number] => 12921499 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/921499
4-aryl-2-anilino-pyrimidines Mar 8, 2009 Issued
Array ( [id] => 7501603 [patent_doc_number] => 20110263546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Polyhydroxylated Bile Acids for Treatment of Biliary Disorders' [patent_app_type] => utility [patent_app_number] => 12/919381 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16225 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263546.pdf [firstpage_image] =>[orig_patent_app_number] => 12919381 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/919381
Polyhydroxylated Bile Acids for Treatment of Biliary Disorders Feb 25, 2009 Abandoned
Array ( [id] => 5576091 [patent_doc_number] => 20090143453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES' [patent_app_type] => utility [patent_app_number] => 12/366968 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12185 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143453.pdf [firstpage_image] =>[orig_patent_app_number] => 12366968 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/366968
METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES Feb 5, 2009 Abandoned
Array ( [id] => 5480752 [patent_doc_number] => 20090203709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/365966 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8867 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203709.pdf [firstpage_image] =>[orig_patent_app_number] => 12365966 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/365966
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor Feb 4, 2009 Abandoned
Array ( [id] => 9059935 [patent_doc_number] => 08546370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Compounds and compositions as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/865339 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81891 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865339 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/865339
Compounds and compositions as kinase inhibitors Jan 26, 2009 Issued
Array ( [id] => 6097605 [patent_doc_number] => 20110003790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/865367 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52652 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003790.pdf [firstpage_image] =>[orig_patent_app_number] => 12865367 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/865367
Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitors Jan 26, 2009 Issued
Array ( [id] => 6618672 [patent_doc_number] => 20100324087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'COMBINED USE OF ANGIOGENESIS INHIBITOR AND TAXANE' [patent_app_type] => utility [patent_app_number] => 12/864817 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12728 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324087.pdf [firstpage_image] =>[orig_patent_app_number] => 12864817 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/864817
COMBINED USE OF ANGIOGENESIS INHIBITOR AND TAXANE Jan 26, 2009 Abandoned
Array ( [id] => 5576102 [patent_doc_number] => 20090143464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent' [patent_app_type] => utility [patent_app_number] => 12/320430 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19644 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143464.pdf [firstpage_image] =>[orig_patent_app_number] => 12320430 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/320430
Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent Jan 25, 2009 Abandoned
Array ( [id] => 5564766 [patent_doc_number] => 20090137619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent' [patent_app_type] => utility [patent_app_number] => 12/320422 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19646 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137619.pdf [firstpage_image] =>[orig_patent_app_number] => 12320422 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/320422
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent Jan 25, 2009 Abandoned
Array ( [id] => 5398414 [patent_doc_number] => 20090318477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'CHEMICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/373524 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 76885 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318477.pdf [firstpage_image] =>[orig_patent_app_number] => 12373524 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/373524
Chemical compounds Jan 12, 2009 Issued
Array ( [id] => 5489995 [patent_doc_number] => 20090291066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => ' COMPOSITION AND METHOD OF TREATING FACIAL SKIN DEFECT' [patent_app_type] => utility [patent_app_number] => 12/351942 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6314 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291066.pdf [firstpage_image] =>[orig_patent_app_number] => 12351942 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/351942
COMPOSITION AND METHOD OF TREATING FACIAL SKIN DEFECT Jan 11, 2009 Abandoned
Array ( [id] => 6561391 [patent_doc_number] => 20100272711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/747147 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39706 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272711.pdf [firstpage_image] =>[orig_patent_app_number] => 12747147 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/747147
COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES Dec 11, 2008 Abandoned
Array ( [id] => 8875797 [patent_doc_number] => 08470763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/747485 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14600 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747485 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/747485
Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof Dec 10, 2008 Issued
Array ( [id] => 6249527 [patent_doc_number] => 20100137449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH' [patent_app_type] => utility [patent_app_number] => 12/331887 [patent_app_country] => US [patent_app_date] => 2008-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 27440 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137449.pdf [firstpage_image] =>[orig_patent_app_number] => 12331887 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/331887
SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH Dec 9, 2008 Abandoned
Menu